NVDA
NVIDIA
-- 138.850 TSLA
Tesla
-- 355.840 INTC
Intel
-- 23.600 BABA
Alibaba
-- 124.730 PLTR
Palantir
-- 119.160 
$Sigilon Therapeutics (SGTX.US)$ Clinical trial to FDA appro...
Clinical trial to FDA approval is normally a long process, which can take 10-15 years, way beyond the cvr expiration date. On top of that they still haven't started pre-clinical on non-primates.
Only play here is a short squeeze, but there's really no shorts. Maybe a fomo play.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call
JustSurface : $Eli Lilly and Co (LLY.US)$ has financed and worked with $Sigilon Therapeutics (SGTX.US)$ since 2018. makes me think they can get this to market pretty quick to offer a buy out at this point
30428008 OP JustSurface : Good luck. You can't just "get to market quickly". FDA process has always been slow and methodical.